Skip to content

Drug interactions

Dasatinib + Entrectinib

Severity: Major

Dasatinib and Entrectinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Entrectinib and dasatinib can each prolong the QT interval, so using them together increases the likelihood of QT-related arrhythmia. Patients with heart failure, bradycardia or electrolyte disturbances are at higher risk.

What this interaction means in plain words

Dasatinib and Entrectinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dasatinib belongs to Oncology; Entrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Avoid concurrent use where feasible. If needed, obtain a baseline ECG, correct electrolytes, and monitor the QTc, reducing or withholding entrectinib if the QTc becomes markedly prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Entrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dasatinib with Entrectinib?

MediHelp rates the interaction as major. Dasatinib and Entrectinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Entrectinib and dasatinib can each prolong the QT interval, so using them together increases the likelihood of QT-related arrhythmia. Patients with heart failure, bradycardia or electrolyte disturbances are at higher risk.

How serious is the interaction between Dasatinib and Entrectinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where feasible. If needed, obtain a baseline ECG, correct electrolytes, and monitor the QTc, reducing or withholding entrectinib if the QTc becomes markedly prolonged.

What other medicines interact with Dasatinib?

MediHelp also lists interactions of Dasatinib with, for example, Saquinavir, Thioridazine, Adagrasib. The full list is on the Dasatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in